S&P 500   0.72 (+6.87%)
DOW   0.72 (+6.87%)
QQQ   271.86 (+2.52%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
S&P 500   0.72 (+6.87%)
DOW   0.72 (+6.87%)
QQQ   271.86 (+2.52%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
S&P 500   0.72 (+6.87%)
DOW   0.72 (+6.87%)
QQQ   271.86 (+2.52%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
S&P 500   0.72 (+6.87%)
DOW   0.72 (+6.87%)
QQQ   271.86 (+2.52%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
Log in

NYSE:ANTMAnthem Stock Price, Forecast & News

$283.18
+2.85 (+1.02 %)
(As of 08/13/2020 04:00 PM ET)
Add
Compare
Today's Range
$280.45
Now: $283.18
$286.18
50-Day Range
$255.00
MA: $267.07
$281.56
52-Week Range
$171.03
Now: $283.18
$309.10
Volume817,100 shs
Average Volume1.76 million shs
Market Capitalization$71.22 billion
P/E Ratio12.30
Dividend Yield1.34%
Beta0.95
Anthem, Inc., through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, such as consumer-driven health plans; and hospital only and limited benefit products. The company also provides a range of managed care services to self-funded customers, including claims processing, underwriting, stop loss insurance, actuarial services, provider network access, medical cost management, disease management, wellness programs, and other administrative services. In addition, it offers an array of specialty and other insurance products and services, such as dental, vision, life and disability insurance benefits, radiology benefit management, and analytics-driven personal health care guidance; and Medicare administrative services. Further, the company provides services to the federal government in connection with the Federal Employee Program; and operates as a licensee of the Blue Cross and Blue Shield Association. As of December 31, 2018, it served 40 million medical members through its affiliated health plans. The company was formerly known as WellPoint, Inc. and changed its name to Anthem, Inc. in December 2014. Anthem, Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Read More
Anthem logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.3Community Rank: 2.5Dividend Strength: 1.7Insider Behavior: 1.0Valuation: 3.1 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.33 out of 5 stars


Industry, Sector and Symbol

Industry Hospital & medical service plans
Sub-IndustryManaged Health Care
SectorMedical
CUSIP94973V10
Phone800-331-1476

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$104.21 billion
Cash Flow$24.80 per share
Book Value$136.99 per share

Profitability

Net Income$4.81 billion

Miscellaneous

Employees70,600
Market Cap$71.22 billion
Next Earnings Date10/28/2020 (Estimated)
OptionableOptionable
$283.18
+2.85 (+1.02 %)
(As of 08/13/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ANTM News and Ratings via Email

Sign-up to receive the latest news and ratings for ANTM and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Anthem (NYSE:ANTM) Frequently Asked Questions

How has Anthem's stock price been impacted by COVID-19?

Anthem's stock was trading at $281.69 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, ANTM stock has increased by 0.5% and is now trading at $283.18.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Anthem?

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Anthem in the last year. There are currently 5 hold ratings and 11 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Anthem
.

When is Anthem's next earnings date?

Anthem is scheduled to release its next quarterly earnings announcement on Wednesday, October 28th 2020.
View our earnings forecast for Anthem
.

How were Anthem's earnings last quarter?

Anthem Inc (NYSE:ANTM) issued its quarterly earnings results on Wednesday, July, 29th. The company reported $9.20 EPS for the quarter, beating analysts' consensus estimates of $8.77 by $0.43. The company had revenue of $29.20 billion for the quarter, compared to analyst estimates of $29.37 billion. Anthem had a return on equity of 19.44% and a net margin of 5.24%. The firm's quarterly revenue was up 15.9% on a year-over-year basis. During the same quarter in the prior year, the business posted $4.64 EPS.
View Anthem's earnings history
.

How often does Anthem pay dividends? What is the dividend yield for Anthem?

Anthem announced a quarterly dividend on Thursday, July 30th. Stockholders of record on Thursday, September 10th will be given a dividend of $0.95 per share on Friday, September 25th. This represents a $3.80 annualized dividend and a yield of 1.34%. The ex-dividend date is Wednesday, September 9th.
View Anthem's dividend history
.

What guidance has Anthem issued on next quarter's earnings?

Anthem updated its FY 2020 Pre-Market earnings guidance on Wednesday, July, 29th. The company provided earnings per share guidance of 22.30 for the period, compared to the Thomson Reuters consensus EPS estimate of $22.33.

What price target have analysts set for ANTM?

16 analysts have issued 1 year price targets for Anthem's shares. Their forecasts range from $262.00 to $423.00. On average, they anticipate Anthem's share price to reach $336.47 in the next year. This suggests a possible upside of 18.8% from the stock's current price.
View analysts' price targets for Anthem
.

Has Anthem been receiving favorable news coverage?

News articles about ANTM stock have trended negative recently, according to InfoTrie. The research firm rates the sentiment of media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Anthem earned a daily sentiment score of -2.4 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the near future.
View the latest news about Anthem
.

Are investors shorting Anthem?

Anthem saw a increase in short interest in June. As of June 30th, there was short interest totaling 3,130,000 shares, an increase of 27.2% from the June 15th total of 2,460,000 shares. Based on an average daily volume of 1,440,000 shares, the days-to-cover ratio is presently 2.2 days. Approximately 1.3% of the company's stock are sold short.
View Anthem's Short Interest
.

Who are some of Anthem's key competitors?

What other stocks do shareholders of Anthem own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Anthem investors own include NVIDIA (NVDA), UnitedHealth Group (UNH), Intel (INTC), Walt Disney (DIS), Alibaba Group (BABA), Visa (V), AbbVie (ABBV), Boeing (BA), Johnson & Johnson (JNJ) and Costco Wholesale (COST).

Who are Anthem's key executives?

Anthem's management team includes the following people:
  • Ms. Gail Koziara Boudreaux, Pres, CEO & Director (Age 58)
  • Mr. John Edward Gallina, Exec. VP & CFO (Age 59)
  • Ms. Gloria Marie McCarthy, Exec. VP and Chief Admin. & Transformation Officer (Age 66)
  • Mr. Thomas Casimir Zielinski Jr., Exec. VP & Gen. Counsel (Age 68)
  • Mr. Peter David Haytaian, Exec. VP and Pres of Commercial & Specialty Bus. Division (Age 49)

What is Anthem's stock symbol?

Anthem trades on the New York Stock Exchange (NYSE) under the ticker symbol "ANTM."

Who are Anthem's major shareholders?

Anthem's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include FMR LLC (3.17%), Nordea Investment Management AB (1.83%), Sanders Capital LLC (1.13%), Bank of New York Mellon Corp (0.95%), First Eagle Investment Management LLC (0.86%) and Sumitomo Mitsui Trust Holdings Inc. (0.58%). Company insiders that own Anthem stock include Gail Boudreaux, Gloria M Mccarthy, Julie A Hill, Peter D Haytaian, Ramiro G Peru, Robert L Dixon Jr, Ronald W Penczek and Thomas C Zielinski.
View institutional ownership trends for Anthem
.

Which institutional investors are selling Anthem stock?

ANTM stock was sold by a variety of institutional investors in the last quarter, including Toronto Dominion Bank, CIBC Private Wealth Group LLC, Retirement Systems of Alabama, Assenagon Asset Management S.A., Unigestion Holding SA, Bank of New York Mellon Corp, Prudential PLC, and BNP PARIBAS ASSET MANAGEMENT Holding S.A.. Company insiders that have sold Anthem company stock in the last year include Gloria M Mccarthy, Julie A Hill, Peter D Haytaian, Robert L Dixon Jr, Ronald W Penczek, and Thomas C Zielinski.
View insider buying and selling activity for Anthem
.

Which institutional investors are buying Anthem stock?

ANTM stock was purchased by a variety of institutional investors in the last quarter, including Nordea Investment Management AB, FMR LLC, Price Wealth LLC, MUFG Securities EMEA plc, Sumitomo Mitsui Trust Holdings Inc., Marshall Wace North America L.P., Wedge Capital Management L L P NC, and Sanders Capital LLC.
View insider buying and selling activity for Anthem
.

How do I buy shares of Anthem?

Shares of ANTM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Anthem's stock price today?

One share of ANTM stock can currently be purchased for approximately $283.18.

How big of a company is Anthem?

Anthem has a market capitalization of $71.22 billion and generates $104.21 billion in revenue each year. The company earns $4.81 billion in net income (profit) each year or $19.44 on an earnings per share basis. Anthem employs 70,600 workers across the globe.

What is Anthem's official website?

The official website for Anthem is www.antheminc.com.

How can I contact Anthem?

Anthem's mailing address is 220 VIRGINIA AVENUE, INDIANAPOLIS IN, 46204. The company can be reached via phone at 800-331-1476 or via email at [email protected]

This page was last updated on 8/13/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.